ONTOLOGY REPORT - ANNOTATIONS
| Term: | hyperactivity |
|
| Accession: | MP:0001399
|
browse the term
|
| Definition: | general restlessness or excessive movement; more frequent movement from one place to another or having an increased state of activity |
| Synonyms: | exact_synonym: | hyperactive; hyperlocomotion; increased locomotor activity; wild running |
| | alt_id: | MP:0001397; MP:0001403 |
|
|
hyperactivity
|
| G |
a |
nonagouti |
|
|
IAGP |
2 |
154,839,306 |
154,876,748 |
RGD:5509061 |
MGI |
| G |
Aadat |
aminoadipate aminotransferase |
|
|
IAGP |
8 |
62,984,921 |
63,024,474 |
RGD:5509061 |
MGI |
| G |
Abca2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
|
|
IAGP |
2 |
25,284,194 |
25,304,059 |
RGD:5509061 |
MGI |
| G |
Abcd2 |
ATP-binding cassette, sub-family D (ALD), member 2 |
|
|
IAGP |
15 |
90,976,302 |
91,022,238 |
RGD:5509061 |
MGI |
| G |
Abcg1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
|
|
IAGP |
17 |
31,194,639 |
31,254,929 |
RGD:5509061 |
MGI |
| G |
Abr |
active BCR-related gene |
|
|
IAGP |
11 |
76,230,236 |
76,391,229 |
RGD:5509061 |
MGI |
| G |
Abr |
active BCR-related gene |
|
|
IAGP |
11 |
76,230,236 |
76,391,229 |
RGD:5509061 |
MGI |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
|
IAGP |
17 |
93,598,762 |
93,604,831 |
RGD:5509061 |
MGI |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
|
IAGP |
17 |
93,598,762 |
93,604,831 |
RGD:5509061 |
MGI |
| G |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
|
|
IAGP |
6 |
55,401,974 |
55,451,449 |
RGD:5509061 |
MGI |
| G |
Adipor2 |
adiponectin receptor 2 |
|
|
IAGP |
6 |
119,303,168 |
119,367,501 |
RGD:5509061 |
MGI |
| G |
Adm |
adrenomedullin |
|
|
IAGP |
7 |
117,771,183 |
117,773,333 |
RGD:5509061 |
MGI |
| G |
Agrp |
agouti related protein |
|
|
IAGP |
8 |
108,090,598 |
108,092,198 |
RGD:5509061 |
MGI |
| G |
Agrp |
agouti related protein |
|
|
IAGP |
8 |
108,090,598 |
108,092,198 |
RGD:5509061 |
MGI |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
IAGP |
8 |
127,080,487 |
127,093,607 |
RGD:5509061 |
MGI |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
|
IAGP |
12 |
113,892,032 |
113,912,487 |
RGD:5509061 |
MGI |
| G |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
|
|
IAGP |
7 |
88,605,285 |
88,638,811 |
RGD:5509061 |
MGI |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
|
IAGP |
10 |
90,452,056 |
90,545,488 |
RGD:5509061 |
MGI |
| G |
Apoe |
apolipoprotein E |
|
|
IAGP |
7 |
20,281,593 |
20,284,515 |
RGD:5509061 |
MGI |
| G |
App |
amyloid beta (A4) precursor protein |
|
|
IAGP |
16 |
84,954,688 |
85,173,948 |
RGD:5509061 |
MGI |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
|
IAGP |
13 |
81,022,683 |
81,035,303 |
RGD:5509061 |
MGI |
| G |
Arsa |
arylsulfatase A |
|
|
IAGP |
15 |
89,302,907 |
89,307,855 |
RGD:5509061 |
MGI |
| G |
Arx |
aristaless related homeobox |
|
|
IAGP |
X |
90,531,985 |
90,543,696 |
RGD:5509061 |
MGI |
| G |
Ate1 |
arginyltransferase 1 |
|
|
IAGP |
7 |
137,535,007 |
137,663,475 |
RGD:5509061 |
MGI |
| G |
Atf2 |
activating transcription factor 2 |
|
|
IAGP |
2 |
73,654,578 |
73,730,685 |
RGD:5509061 |
MGI |
| G |
Atmin |
ATM interactor |
|
|
IAGP |
8 |
119,467,293 |
119,484,345 |
RGD:5509061 |
MGI |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
|
IAGP |
7 |
25,763,186 |
25,790,914 |
RGD:5509061 |
MGI |
| G |
Atrn |
attractin |
|
|
IAGP |
2 |
130,732,232 |
130,856,065 |
RGD:5509061 |
MGI |
| G |
Atxn2 |
ataxin 2 |
|
|
IAGP |
5 |
122,161,618 |
122,264,959 |
RGD:5509061 |
MGI |
| G |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
|
|
IEA |
1 |
145,487,827 |
145,497,067 |
RGD:5509061 |
MGI |
| G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
|
|
IAGP |
15 |
25,293,032 |
25,343,519 |
RGD:5509061 |
MGI |
| G |
Bcr |
breakpoint cluster region |
|
|
IAGP |
10 |
74,523,641 |
74,647,668 |
RGD:5509061 |
MGI |
| G |
Bcr |
breakpoint cluster region |
|
|
IAGP |
10 |
74,523,641 |
74,647,668 |
RGD:5509061 |
MGI |
| G |
Bdnf |
brain derived neurotrophic factor |
|
|
IAGP |
2 |
109,514,857 |
109,567,200 |
RGD:5509061 |
MGI |
| G |
Bdnf |
brain derived neurotrophic factor |
|
|
IAGP |
2 |
109,514,857 |
109,567,200 |
RGD:5509061 |
MGI |
| G |
Bdnf |
brain derived neurotrophic factor |
|
|
IAGP |
2 |
109,514,857 |
109,567,200 |
RGD:5509061 |
MGI |
| G |
Bdnf |
brain derived neurotrophic factor |
|
|
IAGP |
2 |
109,514,857 |
109,567,200 |
RGD:5509061 |
MGI |
| G |
Bdnf |
brain derived neurotrophic factor |
|
|
IAGP |
2 |
109,514,857 |
109,567,200 |
RGD:5509061 |
MGI |
| G |
Bdnf |
brain derived neurotrophic factor |
|
|
IAGP |
2 |
109,514,857 |
109,567,200 |
RGD:5509061 |
MGI |
| G |
Braf |
Braf transforming gene |
|
|
IAGP |
6 |
39,553,236 |
39,675,462 |
RGD:5509061 |
MGI |
| G |
Braf |
Braf transforming gene |
|
|
IAGP |
6 |
39,553,236 |
39,675,462 |
RGD:5509061 |
MGI |
| G |
Brca1 |
breast cancer 1 |
|
|
IAGP |
11 |
101,350,078 |
101,413,269 |
RGD:5509061 |
MGI |
| G |
Btbd9 |
BTB (POZ) domain containing 9 |
|
|
IAGP |
17 |
30,352,469 |
30,713,232 |
RGD:5509061 |
MGI |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
|
IAGP |
2 |
24,461,895 |
24,618,672 |
RGD:5509061 |
MGI |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
|
IAGP |
11 |
94,269,705 |
94,335,512 |
RGD:5509061 |
MGI |
| G |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
|
|
IEA |
14 |
29,718,129 |
30,535,050 |
RGD:5509061 |
MGI |
| G |
Cacng2 |
calcium channel, voltage-dependent, gamma subunit 2 |
|
|
IAGP |
15 |
77,824,053 |
77,949,710 |
RGD:5509061 |
MGI |
| G |
Cadps2 |
Ca2+-dependent activator protein for secretion 2 |
|
|
IAGP |
6 |
23,212,838 |
23,789,300 |
RGD:5509061 |
MGI |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
|
IAGP |
18 |
61,085,286 |
61,147,806 |
RGD:5509061 |
MGI |
| G |
Cbl |
Casitas B-lineage lymphoma |
|
|
IAGP |
9 |
43,957,345 |
44,042,129 |
RGD:5509061 |
MGI |
| G |
Cckar |
cholecystokinin A receptor |
|
|
IAGP |
5 |
54,089,724 |
54,098,943 |
RGD:5509061 |
MGI |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
IAGP |
7 |
112,574,334 |
112,584,852 |
RGD:5509061 |
MGI |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
IAGP |
7 |
112,574,334 |
112,584,852 |
RGD:5509061 |
MGI |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
IAGP |
7 |
112,574,334 |
112,584,852 |
RGD:5509061 |
MGI |
| G |
Cdh23 |
cadherin 23 (otocadherin) |
|
|
IAGP |
10 |
59,766,022 |
60,159,238 |
RGD:5509061 |
MGI |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
|
IAGP |
10 |
126,500,659 |
126,504,339 |
RGD:5509061 |
MGI |
| G |
Cdkl5 |
cyclin-dependent kinase-like 5 |
|
|
IAGP |
X |
157,222,240 |
157,432,613 |
RGD:5509061 |
MGI |
| G |
Celf4 |
CUGBP, Elav-like family member 4 |
|
|
IAGP |
18 |
25,636,121 |
25,912,484 |
RGD:5509061 |
MGI |
| G |
Cers1 |
ceramide synthase 1 |
|
|
IAGP |
8 |
72,839,674 |
72,855,487 |
RGD:5509061 |
MGI |
| G |
Ces1d |
carboxylesterase 1D |
|
|
IAGP |
8 |
95,689,971 |
95,721,703 |
RGD:5509061 |
MGI |
| G |
Chat |
choline acetyltransferase |
|
|
IAGP |
14 |
33,221,389 |
33,279,095 |
RGD:5509061 |
MGI |
| G |
Chrd |
chordin |
|
|
IAGP |
16 |
20,733,200 |
20,742,457 |
RGD:5509061 |
MGI |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1, CNS |
|
|
IAGP |
19 |
8,738,495 |
8,758,096 |
RGD:5509061 |
MGI |
| G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
|
|
IAGP |
2 |
91,762,346 |
91,769,986 |
RGD:5509061 |
MGI |
| G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
|
|
IAGP |
2 |
91,762,346 |
91,769,986 |
RGD:5509061 |
MGI |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
|
|
IAGP |
7 |
70,243,578 |
70,357,412 |
RGD:5509061 |
MGI |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
|
|
IAGP |
3 |
89,557,370 |
89,568,554 |
RGD:5509061 |
MGI |
| G |
Chrnb3 |
cholinergic receptor, nicotinic, beta polypeptide 3 |
|
|
IAGP |
8 |
28,479,183 |
28,510,202 |
RGD:5509061 |
MGI |
| G |
Clcn3 |
chloride channel 3 |
|
|
IAGP |
8 |
63,389,186 |
63,462,108 |
RGD:5509061 |
MGI |
| G |
Clcn3 |
chloride channel 3 |
|
|
IAGP |
8 |
63,389,186 |
63,462,108 |
RGD:5509061 |
MGI |
| G |
Clock |
circadian locomotor output cycles kaput |
|
|
IAGP |
5 |
76,641,202 |
76,733,573 |
RGD:5509061 |
MGI |
| G |
Clock |
circadian locomotor output cycles kaput |
|
|
IAGP |
5 |
76,641,202 |
76,733,573 |
RGD:5509061 |
MGI |
| G |
Clock |
circadian locomotor output cycles kaput |
|
|
IAGP |
5 |
76,641,202 |
76,733,573 |
RGD:5509061 |
MGI |
| G |
Clock |
circadian locomotor output cycles kaput |
|
|
IAGP |
5 |
76,641,202 |
76,733,573 |
RGD:5509061 |
MGI |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
|
IAGP |
4 |
34,011,607 |
34,035,806 |
RGD:5509061 |
MGI |
| G |
Cntnap2 |
contactin associated protein-like 2 |
|
|
IAGP |
6 |
45,010,060 |
47,251,387 |
RGD:5509061 |
MGI |
| G |
Crem |
cAMP responsive element modulator |
|
|
IAGP |
18 |
3,266,352 |
3,337,587 |
RGD:5509061 |
MGI |
| G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
|
IAGP |
11 |
103,994,196 |
104,036,832 |
RGD:5509061 |
MGI |
| G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
|
IAGP |
11 |
103,994,196 |
104,036,832 |
RGD:5509061 |
MGI |
| G |
Dbh |
dopamine beta hydroxylase |
|
|
IAGP |
2 |
27,021,027 |
27,038,724 |
RGD:5509061 |
MGI |
| G |
Dbh |
dopamine beta hydroxylase |
|
|
IAGP |
2 |
27,021,027 |
27,038,724 |
RGD:5509061 |
MGI |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
|
IAGP |
15 |
76,332,445 |
76,342,248 |
RGD:5509061 |
MGI |
| G |
Disc1 |
disrupted in schizophrenia 1 |
|
|
IAGP |
8 |
127,578,095 |
127,785,051 |
RGD:5509061 |
MGI |
| G |
Dkk3 |
dickkopf homolog 3 (Xenopus laevis) |
|
|
IAGP |
7 |
119,259,533 |
119,302,571 |
RGD:5509061 |
MGI |
| G |
Dll1 |
delta-like 1 (Drosophila) |
|
|
IAGP |
17 |
15,504,318 |
15,512,787 |
RGD:5509061 |
MGI |
| G |
Drd1a |
dopamine receptor D1A |
|
|
IAGP |
13 |
54,146,552 |
54,151,027 |
RGD:5509061 |
MGI |
| G |
Drd1a |
dopamine receptor D1A |
|
|
IAGP |
13 |
54,146,552 |
54,151,027 |
RGD:5509061 |
MGI |
| G |
Drd1a |
dopamine receptor D1A |
|
|
IAGP |
13 |
54,146,552 |
54,151,027 |
RGD:5509061 |
MGI |
| G |
Drd2 |
dopamine receptor D2 |
|
|
IAGP |
9 |
49,148,767 |
49,215,319 |
RGD:5509061 |
MGI |
| G |
Drd2 |
dopamine receptor D2 |
|
|
IAGP |
9 |
49,148,767 |
49,215,319 |
RGD:5509061 |
MGI |
| G |
Drd3 |
dopamine receptor D3 |
|
|
IAGP |
16 |
43,762,355 |
43,822,952 |
RGD:5509061 |
MGI |
| G |
Drd3 |
dopamine receptor D3 |
|
|
IAGP |
16 |
43,762,355 |
43,822,952 |
RGD:5509061 |
MGI |
| G |
Drd3 |
dopamine receptor D3 |
|
|
IAGP |
16 |
43,762,355 |
43,822,952 |
RGD:5509061 |
MGI |
| G |
Drd3 |
dopamine receptor D3 |
|
|
IAGP |
16 |
43,762,355 |
43,822,952 |
RGD:5509061 |
MGI |
| G |
Emx1 |
empty spiracles homeobox 1 |
|
|
IAGP |
6 |
85,137,925 |
85,154,457 |
RGD:5509061 |
MGI |
| G |
Emx1 |
empty spiracles homeobox 1 |
|
|
IAGP |
6 |
85,137,925 |
85,154,457 |
RGD:5509061 |
MGI |
| G |
En1 |
engrailed 1 |
|
|
IAGP |
1 |
122,499,064 |
122,504,568 |
RGD:5509061 |
MGI |
| G |
En1 |
engrailed 1 |
|
|
IAGP |
1 |
122,499,064 |
122,504,568 |
RGD:5509061 |
MGI |
| G |
En2 |
engrailed 2 |
|
|
IAGP |
5 |
28,492,236 |
28,498,706 |
RGD:5509061 |
MGI |
| G |
Eno2 |
enolase 2, gamma neuronal |
|
|
IAGP |
6 |
124,710,073 |
124,719,527 |
RGD:5509061 |
MGI |
| G |
Eomes |
eomesodermin homolog (Xenopus laevis) |
|
|
IAGP |
9 |
118,387,307 |
118,395,250 |
RGD:5509061 |
MGI |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
IAGP |
1 |
68,086,540 |
69,154,633 |
RGD:5509061 |
MGI |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
IAGP |
1 |
68,086,540 |
69,154,633 |
RGD:5509061 |
MGI |
| G |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
|
|
IAGP |
18 |
32,399,985 |
32,429,801 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Ext1 |
exostoses (multiple) 1 |
|
|
IAGP |
15 |
52,899,816 |
53,177,738 |
RGD:5509061 |
MGI |
| G |
Fasn |
fatty acid synthase |
|
|
IAGP |
11 |
120,667,272 |
120,685,861 |
RGD:5509061 |
MGI |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
|
IAGP |
9 |
36,651,244 |
36,686,225 |
RGD:5509061 |
MGI |
| G |
Fezf2 |
Fez family zinc finger 2 |
|
|
IAGP |
14 |
13,174,406 |
13,178,379 |
RGD:5509061 |
MGI |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
|
IAGP |
16 |
28,160,184 |
28,753,288 |
RGD:5509061 |
MGI |
| G |
Fgf13 |
fibroblast growth factor 13 |
|
|
IAGP |
X |
56,315,327 |
56,387,613 |
RGD:5509061 |
MGI |
| G |
Fgf14 |
fibroblast growth factor 14 |
|
|
IAGP |
14 |
124,377,513 |
125,076,349 |
RGD:5509061 |
MGI |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
|
IAGP |
7 |
152,024,517 |
152,029,253 |
RGD:5509061 |
MGI |
| G |
Fmr1 |
fragile X mental retardation syndrome 1 |
|
|
IAGP |
X |
65,931,730 |
65,971,138 |
RGD:5509061 |
MGI |
| G |
Fmr1 |
fragile X mental retardation syndrome 1 |
|
|
IAGP |
X |
65,931,730 |
65,971,138 |
RGD:5509061 |
MGI |
| G |
Fmr1 |
fragile X mental retardation syndrome 1 |
|
|
IAGP |
X |
65,931,730 |
65,971,138 |
RGD:5509061 |
MGI |
| G |
Fmr1 |
fragile X mental retardation syndrome 1 |
|
|
IAGP |
X |
65,931,730 |
65,971,138 |
RGD:5509061 |
MGI |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
|
IAGP |
12 |
86,814,851 |
86,818,219 |
RGD:5509061 |
MGI |
| G |
Foxa2 |
forkhead box A2 |
|
|
IAGP |
2 |
147,868,614 |
147,872,705 |
RGD:5509061 |
MGI |
| G |
Foxi1 |
forkhead box I1 |
|
|
IAGP |
11 |
34,104,341 |
34,108,089 |
RGD:5509061 |
MGI |
| G |
Fxr2 |
fragile X mental retardation, autosomal homolog 2 |
|
|
IAGP |
11 |
69,446,473 |
69,466,799 |
RGD:5509061 |
MGI |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
|
|
IAGP |
17 |
37,182,911 |
37,211,250 |
RGD:5509061 |
MGI |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
|
|
IAGP |
17 |
37,182,911 |
37,211,250 |
RGD:5509061 |
MGI |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
|
|
IAGP |
4 |
46,676,770 |
47,004,586 |
RGD:5509061 |
MGI |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
|
|
IAGP |
11 |
41,944,982 |
41,996,432 |
RGD:5509061 |
MGI |
| G |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
|
|
IAGP |
X |
69,678,015 |
69,901,585 |
RGD:5509061 |
MGI |
| G |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
|
|
IAGP |
7 |
64,663,039 |
64,765,379 |
RGD:5509061 |
MGI |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
|
|
IAGP |
11 |
42,233,259 |
42,446,093 |
RGD:5509061 |
MGI |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
|
|
IAGP |
7 |
64,845,904 |
65,084,172 |
RGD:5509061 |
MGI |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
|
|
IAGP |
7 |
64,845,904 |
65,084,172 |
RGD:5509061 |
MGI |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
|
|
IAGP |
7 |
64,845,904 |
65,084,172 |
RGD:5509061 |
MGI |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
|
|
IAGP |
11 |
41,723,697 |
41,814,180 |
RGD:5509061 |
MGI |
| G |
Gfi1 |
growth factor independent 1 |
|
|
IAGP |
5 |
108,145,674 |
108,153,363 |
RGD:5509061 |
MGI |
| G |
Git1 |
G protein-coupled receptor kinase-interactor 1 |
|
|
IAGP |
11 |
77,306,914 |
77,321,276 |
RGD:5509061 |
MGI |
| G |
Glra1 |
glycine receptor, alpha 1 subunit |
|
|
IAGP |
11 |
55,328,315 |
55,421,292 |
RGD:5509061 |
MGI |
| G |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
|
|
IAGP |
18 |
67,247,990 |
67,386,446 |
RGD:5509061 |
MGI |
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
|
IAGP |
2 |
174,109,821 |
174,172,245 |
RGD:5509061 |
MGI |
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
|
IAGP |
2 |
174,109,821 |
174,172,245 |
RGD:5509061 |
MGI |
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
|
IAGP |
2 |
174,109,821 |
174,172,245 |
RGD:5509061 |
MGI |
| G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
|
|
IAGP |
10 |
80,411,369 |
80,477,670 |
RGD:5509061 |
MGI |
| G |
Gpr21 |
G protein-coupled receptor 21 |
|
|
IAGP |
2 |
37,372,146 |
37,374,801 |
RGD:5509061 |
MGI |
| G |
Gpr50 |
G-protein-coupled receptor 50 |
|
|
IAGP |
X |
68,916,942 |
68,921,264 |
RGD:5509061 |
MGI |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
|
IAGP |
11 |
56,825,193 |
57,143,746 |
RGD:5509061 |
MGI |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
|
IAGP |
11 |
56,825,193 |
57,143,746 |
RGD:5509061 |
MGI |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
|
IAGP |
3 |
80,488,858 |
80,606,713 |
RGD:5509061 |
MGI |
| G |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
|
|
IEA |
9 |
4,417,893 |
4,796,234 |
RGD:5509061 |
MGI |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
|
IAGP |
6 |
63,206,851 |
64,616,273 |
RGD:5509061 |
MGI |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
|
IAGP |
2 |
25,146,697 |
25,174,683 |
RGD:5509061 |
MGI |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
|
IAGP |
2 |
25,146,697 |
25,174,683 |
RGD:5509061 |
MGI |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
|
IAGP |
2 |
25,146,697 |
25,174,683 |
RGD:5509061 |
MGI |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
|
IAGP |
2 |
25,146,697 |
25,174,683 |
RGD:5509061 |
MGI |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
|
IAGP |
2 |
25,146,697 |
25,174,683 |
RGD:5509061 |
MGI |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
|
IAGP |
6 |
135,679,813 |
136,123,529 |
RGD:5509061 |
MGI |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
|
IAGP |
6 |
135,679,813 |
136,123,529 |
RGD:5509061 |
MGI |
| G |
Grk6 |
G protein-coupled receptor kinase 6 |
|
|
IAGP |
13 |
55,546,695 |
55,562,288 |
RGD:5509061 |
MGI |
| G |
Grm2 |
glutamate receptor, metabotropic 2 |
|
|
IAGP |
9 |
106,546,865 |
106,558,440 |
RGD:5509061 |
MGI |
| G |
Grpr |
gastrin releasing peptide receptor |
|
|
IAGP |
X |
159,951,836 |
159,987,579 |
RGD:5509061 |
MGI |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
|
IAGP |
3 |
107,815,168 |
107,820,891 |
RGD:5509061 |
MGI |
| G |
Gt(ROSA)26Sor |
gene trap ROSA 26, Philippe Soriano |
|
|
IAGP |
6 |
113,017,422 |
113,027,238 |
RGD:5509061 |
MGI |
| G |
Gt(ROSA)26Sor |
gene trap ROSA 26, Philippe Soriano |
|
|
IAGP |
6 |
113,017,422 |
113,027,238 |
RGD:5509061 |
MGI |
| G |
Gt(ROSA)26Sor |
gene trap ROSA 26, Philippe Soriano |
|
|
IAGP |
6 |
113,017,422 |
113,027,238 |
RGD:5509061 |
MGI |
| G |
Gtf2ird1 |
general transcription factor II I repeat domain-containing 1 |
|
|
IAGP |
5 |
134,833,531 |
134,932,581 |
RGD:5509061 |
MGI |
| G |
Hdac4 |
histone deacetylase 4 |
|
|
IAGP |
1 |
93,829,311 |
94,044,970 |
RGD:5509061 |
MGI |
| G |
Hmx2 |
H6 homeobox 2 |
|
|
IAGP |
7 |
138,697,576 |
138,700,096 |
RGD:5509061 |
MGI |
| G |
Hmx2 |
H6 homeobox 2 |
|
|
IAGP |
7 |
138,697,576 |
138,700,096 |
RGD:5509061 |
MGI |
| G |
Hmx3 |
H6 homeobox 3 |
|
|
IAGP |
7 |
138,686,477 |
138,688,450 |
RGD:5509061 |
MGI |
| G |
Hmx3 |
H6 homeobox 3 |
|
|
IAGP |
7 |
138,686,477 |
138,688,450 |
RGD:5509061 |
MGI |
| G |
Hmx3 |
H6 homeobox 3 |
|
|
IAGP |
7 |
138,686,477 |
138,688,450 |
RGD:5509061 |
MGI |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
|
|
IAGP |
13 |
106,233,773 |
106,238,213 |
RGD:5509061 |
MGI |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
|
|
IAGP |
X |
143,397,056 |
143,631,820 |
RGD:5509061 |
MGI |
| G |
Htt |
huntingtin |
|
|
IAGP |
5 |
35,104,389 |
35,252,045 |
RGD:5509061 |
MGI |
| G |
Htt |
huntingtin |
|
|
IAGP |
5 |
35,104,389 |
35,252,045 |
RGD:5509061 |
MGI |
| G |
Htt |
huntingtin |
|
|
IAGP |
5 |
35,104,389 |
35,252,045 |
RGD:5509061 |
MGI |
| G |
Il6 |
interleukin 6 |
|
|
IAGP |
5 |
30,339,701 |
30,346,508 |
RGD:5509061 |
MGI |
| G |
Impa1 |
inositol (myo)-1(or 4)-monophosphatase 1 |
|
|
IAGP |
3 |
10,313,540 |
10,331,439 |
RGD:5509061 |
MGI |
| G |
Kalrn |
kalirin, RhoGEF kinase |
|
|
IAGP |
16 |
33,969,159 |
34,514,113 |
RGD:5509061 |
MGI |
| G |
Kansl1 |
KAT8 regulatory NSL complex subunit 1 |
|
|
IAGP |
11 |
104,194,543 |
104,303,605 |
RGD:5509061 |
MGI |
| G |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
|
|
IAGP |
7 |
53,651,838 |
53,694,074 |
RGD:5509061 |
MGI |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
|
IAGP |
7 |
51,846,256 |
51,860,121 |
RGD:5509061 |
MGI |
| G |
Kcne1 |
potassium voltage-gated channel, Isk-related subfamily, member 1 |
|
|
IAGP |
16 |
92,346,246 |
92,359,713 |
RGD:5509061 |
MGI |
| G |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
|
|
IAGP |
2 |
127,282,234 |
127,347,106 |
RGD:5509061 |
MGI |
| G |
Kcnq1 |
potassium voltage-gated channel, subfamily Q, member 1 |
|
|
IAGP |
7 |
150,293,159 |
150,612,947 |
RGD:5509061 |
MGI |
| G |
Kcnq1 |
potassium voltage-gated channel, subfamily Q, member 1 |
|
|
IAGP |
7 |
150,293,159 |
150,612,947 |
RGD:5509061 |
MGI |
| G |
Kcnq1 |
potassium voltage-gated channel, subfamily Q, member 1 |
|
|
IAGP |
7 |
150,293,159 |
150,612,947 |
RGD:5509061 |
MGI |
| G |
Kcnq1 |
potassium voltage-gated channel, subfamily Q, member 1 |
|
|
IAGP |
7 |
150,293,159 |
150,612,947 |
RGD:5509061 |
MGI |
| G |
L1cam |
L1 cell adhesion molecule |
|
|
IAGP |
X |
71,099,119 |
71,126,173 |
RGD:5509061 |
MGI |
| G |
Lclat1 |
lysocardiolipin acyltransferase 1 |
|
|
IAGP |
17 |
73,457,325 |
73,592,708 |
RGD:5509061 |
MGI |
| G |
Ldlr |
low density lipoprotein receptor |
|
|
IAGP |
9 |
21,528,038 |
21,554,363 |
RGD:5509061 |
MGI |
| G |
Ldlr |
low density lipoprotein receptor |
|
|
IAGP |
9 |
21,528,038 |
21,554,363 |
RGD:5509061 |
MGI |
| G |
Lepr |
leptin receptor |
|
|
IAGP |
4 |
101,390,012 |
101,487,959 |
RGD:5509061 |
MGI |
| G |
Lgals8 |
lectin, galactose binding, soluble 8 |
|
|
IEA |
13 |
12,531,686 |
12,553,757 |
RGD:5509061 |
MGI |
| G |
Limk1 |
LIM-domain containing, protein kinase |
|
|
IAGP |
5 |
135,131,909 |
135,164,460 |
RGD:5509061 |
MGI |
| G |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
|
|
IAGP |
1 |
169,619,689 |
169,778,864 |
RGD:5509061 |
MGI |
| G |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
|
|
IAGP |
1 |
169,619,689 |
169,778,864 |
RGD:5509061 |
MGI |
| G |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
|
|
IAGP |
1 |
169,619,689 |
169,778,864 |
RGD:5509061 |
MGI |
| G |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
|
|
IAGP |
1 |
169,619,689 |
169,778,864 |
RGD:5509061 |
MGI |
| G |
Lphn3 |
latrophilin 3 |
|
|
IAGP |
5 |
81,450,618 |
82,224,755 |
RGD:5509061 |
MGI |
| G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
|
|
IAGP |
10 |
126,975,213 |
127,058,204 |
RGD:5509061 |
MGI |
| G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
|
|
IAGP |
10 |
126,975,213 |
127,058,204 |
RGD:5509061 |
MGI |
| G |
Lrrc4 |
leucine rich repeat containing 4 |
|
|
IAGP |
6 |
28,778,126 |
28,781,747 |
RGD:5509061 |
MGI |
| G |
Lrrc7 |
leucine rich repeat containing 7 |
|
|
IAGP |
3 |
157,747,403 |
158,225,185 |
RGD:5509061 |
MGI |
| G |
Lsamp |
limbic system-associated membrane protein |
|
|
IAGP |
16 |
41,533,455 |
42,146,326 |
RGD:5509061 |
MGI |
| G |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
|
|
IEA |
2 |
160,189,413 |
160,192,801 |
RGD:5509061 |
MGI |
| G |
Maob |
monoamine oxidase B |
|
|
IAGP |
X |
16,286,407 |
16,394,492 |
RGD:5509061 |
MGI |
| G |
Map6 |
microtubule-associated protein 6 |
|
|
IAGP |
7 |
106,415,957 |
106,485,647 |
RGD:5509061 |
MGI |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
|
IAGP |
7 |
133,903,140 |
133,909,330 |
RGD:5509061 |
MGI |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
|
IAGP |
7 |
133,903,140 |
133,909,330 |
RGD:5509061 |
MGI |
| G |
Mapt |
microtubule-associated protein tau |
|
|
IAGP |
11 |
104,092,750 |
104,193,410 |
RGD:5509061 |
MGI |
| G |
Mark4 |
MAP/microtubule affinity-regulating kinase 4 |
|
|
IAGP |
7 |
20,011,424 |
20,043,843 |
RGD:5509061 |
MGI |
| G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
|
IAGP |
15 |
81,065,929 |
81,069,394 |
RGD:5509061 |
MGI |
| G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
|
IAGP |
15 |
81,065,929 |
81,069,394 |
RGD:5509061 |
MGI |
| G |
Mcoln3 |
mucolipin 3 |
|
|
IEA |
3 |
145,784,755 |
145,803,610 |
RGD:5509061 |
MGI |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
|
IAGP |
X |
71,272,160 |
71,330,975 |
RGD:5509061 |
MGI |
| G |
Mgll |
monoglyceride lipase |
|
|
IAGP |
6 |
88,674,406 |
88,778,354 |
RGD:5509061 |
MGI |
| G |
Mid1 |
midline 1 |
|
|
IAGP |
X |
166,123,179 |
166,428,730 |
RGD:5509061 |
MGI |
| G |
Myo6 |
myosin VI |
|
|
IAGP |
9 |
80,012,841 |
80,159,536 |
RGD:5509061 |
MGI |
| G |
Myo6 |
myosin VI |
|
|
IAGP |
9 |
80,012,841 |
80,159,536 |
RGD:5509061 |
MGI |
| G |
Myo6 |
myosin VI |
|
|
IAGP |
9 |
80,012,841 |
80,159,536 |
RGD:5509061 |
MGI |
| G |
Myo7a |
myosin VIIA |
|
|
IAGP |
7 |
105,199,570 |
105,268,003 |
RGD:5509061 |
MGI |
| G |
Ncdn |
neurochondrin |
|
|
IAGP |
4 |
126,420,994 |
126,430,673 |
RGD:5509061 |
MGI |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
|
IAGP |
11 |
62,130,192 |
62,270,834 |
RGD:5509061 |
MGI |
| G |
Nespas |
neuroendocrine secretory protein antisense |
|
|
IAGP |
2 |
174,106,738 |
174,120,937 |
RGD:5509061 |
MGI |
| G |
Neurod1 |
neurogenic differentiation 1 |
|
|
IAGP |
2 |
79,292,798 |
79,296,793 |
RGD:5509061 |
MGI |
| G |
Neurod6 |
neurogenic differentiation 6 |
|
|
IAGP |
6 |
55,627,812 |
55,631,257 |
RGD:5509061 |
MGI |
| G |
Neurod6 |
neurogenic differentiation 6 |
|
|
IAGP |
6 |
55,627,812 |
55,631,257 |
RGD:5509061 |
MGI |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
|
IAGP |
12 |
57,632,922 |
57,637,895 |
RGD:5509061 |
MGI |
| G |
Nlgn3 |
neuroligin 3 |
|
|
IAGP |
X |
98,494,520 |
98,516,689 |
RGD:5509061 |
MGI |
| G |
Nox3 |
NADPH oxidase 3 |
|
|
IEA |
17 |
3,635,240 |
3,696,261 |
RGD:5509061 |
MGI |
| G |
Npas1 |
neuronal PAS domain protein 1 |
|
|
IAGP |
7 |
17,041,070 |
17,062,129 |
RGD:5509061 |
MGI |
| G |
Npas3 |
neuronal PAS domain protein 3 |
|
|
IAGP |
12 |
54,349,664 |
55,173,162 |
RGD:5509061 |
MGI |
| G |
Npy1r |
neuropeptide Y receptor Y1 |
|
|
IAGP |
8 |
69,221,321 |
69,230,697 |
RGD:5509061 |
MGI |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
|
IAGP |
2 |
56,959,637 |
56,976,414 |
RGD:5509061 |
MGI |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
|
IAGP |
2 |
56,959,637 |
56,976,414 |
RGD:5509061 |
MGI |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
|
IAGP |
4 |
48,064,120 |
48,096,224 |
RGD:5509061 |
MGI |
| G |
Nrg1 |
neuregulin 1 |
|
|
IAGP |
8 |
32,928,500 |
33,028,675 |
RGD:5509061 |
MGI |
| G |
Nrg1 |
neuregulin 1 |
|
|
IAGP |
8 |
32,928,500 |
33,028,675 |
RGD:5509061 |
MGI |
| G |
Ntf5 |
neurotrophin 5 |
|
|
IAGP |
7 |
52,669,065 |
52,672,549 |
RGD:5509061 |
MGI |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
IAGP |
13 |
58,907,957 |
59,231,337 |
RGD:5509061 |
MGI |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
IAGP |
13 |
58,907,957 |
59,231,337 |
RGD:5509061 |
MGI |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
IAGP |
13 |
58,907,957 |
59,231,337 |
RGD:5509061 |
MGI |
| G |
Ophn1 |
oligophrenin 1 |
|
|
IAGP |
X |
95,752,854 |
96,086,324 |
RGD:5509061 |
MGI |
| G |
Oprd1 |
opioid receptor, delta 1 |
|
|
IAGP |
4 |
131,666,641 |
131,700,401 |
RGD:5509061 |
MGI |
| G |
Otc |
ornithine transcarbamylase |
|
|
IAGP |
X |
9,829,485 |
9,898,150 |
RGD:5509061 |
MGI |
| G |
Otog |
otogelin |
|
|
IAGP |
7 |
53,496,357 |
53,566,804 |
RGD:5509061 |
MGI |
| G |
Oxtr |
oxytocin receptor |
|
|
IAGP |
6 |
112,423,678 |
112,439,802 |
RGD:5509061 |
MGI |
| G |
Pcdh15 |
protocadherin 15 |
|
|
IEA |
10 |
73,284,615 |
74,112,482 |
RGD:5509061 |
MGI |
| G |
Pde11a |
phosphodiesterase 11A |
|
|
IAGP |
2 |
75,829,189 |
76,176,710 |
RGD:5509061 |
MGI |
| G |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
|
|
IAGP |
15 |
103,333,729 |
103,360,483 |
RGD:5509061 |
MGI |
| G |
Pitx3 |
paired-like homeodomain transcription factor 3 |
|
|
IAGP |
19 |
46,210,175 |
46,222,815 |
RGD:5509061 |
MGI |
| G |
Pkd2l2 |
polycystic kidney disease 2-like 2 |
|
|
IEA |
18 |
34,569,077 |
34,602,443 |
RGD:5509061 |
MGI |
| G |
Pla2g6 |
phospholipase A2, group VI |
|
|
IAGP |
15 |
79,116,658 |
79,158,598 |
RGD:5509061 |
MGI |
| G |
Plcb1 |
phospholipase C, beta 1 |
|
|
IAGP |
2 |
134,611,900 |
135,300,994 |
RGD:5509061 |
MGI |
| G |
Plin5 |
perilipin 5 |
|
|
IAGP |
17 |
56,251,024 |
56,256,971 |
RGD:5509061 |
MGI |
| G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
|
|
IAGP |
8 |
3,515,384 |
3,544,267 |
RGD:5509061 |
MGI |
| G |
Pou4f3 |
POU domain, class 4, transcription factor 3 |
|
|
IAGP |
18 |
42,554,251 |
42,555,747 |
RGD:5509061 |
MGI |
| G |
Pou4f3 |
POU domain, class 4, transcription factor 3 |
|
|
IAGP |
18 |
42,554,251 |
42,555,747 |
RGD:5509061 |
MGI |
| G |
Pou4f3 |
POU domain, class 4, transcription factor 3 |
|
|
IAGP |
18 |
42,554,251 |
42,555,747 |
RGD:5509061 |
MGI |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
|
IAGP |
6 |
115,311,239 |
115,440,419 |
RGD:5509061 |
MGI |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
|
IAGP |
5 |
51,845,488 |
51,945,160 |
RGD:5509061 |
MGI |
| G |
Ppm1f |
protein phosphatase 1F (PP2C domain containing) |
|
|
IEA |
16 |
16,903,414 |
16,927,455 |
RGD:5509061 |
MGI |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
|
IAGP |
11 |
98,210,052 |
98,219,109 |
RGD:5509061 |
MGI |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isoform |
|
|
IAGP |
14 |
21,318,536 |
21,365,795 |
RGD:5509061 |
MGI |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) |
|
|
IAGP |
11 |
17,059,301 |
17,100,383 |
RGD:5509061 |
MGI |
| G |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
|
|
IAGP |
12 |
32,643,344 |
32,746,144 |
RGD:5509061 |
MGI |
| G |
Prnp |
prion protein |
|
|
IAGP |
2 |
131,735,664 |
131,764,167 |
RGD:5509061 |
MGI |
| G |
Prnp |
prion protein |
|
|
IAGP |
2 |
131,735,664 |
131,764,167 |
RGD:5509061 |
MGI |
| G |
Psap |
prosaposin |
|
|
IAGP |
10 |
59,740,376 |
59,765,348 |
RGD:5509061 |
MGI |
| G |
Psap |
prosaposin |
|
|
IAGP |
10 |
59,740,376 |
59,765,348 |
RGD:5509061 |
MGI |
| G |
Psen1 |
presenilin 1 |
|
|
IAGP |
12 |
85,029,513 |
85,076,149 |
RGD:5509061 |
MGI |
| G |
Psen2 |
presenilin 2 |
|
|
IAGP |
1 |
182,157,135 |
182,186,431 |
RGD:5509061 |
MGI |
| G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
|
IAGP |
4 |
117,880,818 |
117,964,002 |
RGD:5509061 |
MGI |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
|
IAGP |
14 |
12,386,067 |
13,074,553 |
RGD:5509061 |
MGI |
| G |
Pvalb |
parvalbumin |
|
|
IAGP |
15 |
78,021,547 |
78,036,781 |
RGD:5509061 |
MGI |
| G |
Rai1 |
retinoic acid induced 1 |
|
|
IAGP |
11 |
59,918,515 |
60,012,697 |
RGD:5509061 |
MGI |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
|
IAGP |
16 |
92,392,198 |
92,466,391 |
RGD:5509061 |
MGI |
| G |
Rcan2 |
regulator of calcineurin 2 |
|
|
IAGP |
17 |
43,938,800 |
44,176,465 |
RGD:5509061 |
MGI |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
|
IAGP |
1 |
171,671,608 |
171,677,773 |
RGD:5509061 |
MGI |
| G |
Ryr3 |
ryanodine receptor 3 |
|
|
IAGP |
2 |
112,471,537 |
112,870,488 |
RGD:5509061 |
MGI |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
|
IAGP |
15 |
3,220,767 |
3,230,508 |
RGD:5509061 |
MGI |
| G |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
|
|
IAGP |
X |
156,065,340 |
156,413,849 |
RGD:5509061 |
MGI |
| G |
Shank2 |
SH3/ankyrin domain gene 2 |
|
|
IAGP |
7 |
151,361,425 |
151,608,580 |
RGD:5509061 |
MGI |
| G |
Shank2 |
SH3/ankyrin domain gene 2 |
|
|
IAGP |
7 |
151,361,425 |
151,608,580 |
RGD:5509061 |
MGI |
| G |
Shh |
sonic hedgehog |
|
|
IAGP |
5 |
28,783,380 |
28,793,641 |
RGD:5509061 |
MGI |
| G |
Sirt1 |
sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) |
|
|
IAGP |
10 |
62,781,753 |
62,801,783 |
RGD:5509061 |
MGI |
| G |
Slc12a2 |
solute carrier family 12, member 2 |
|
|
IAGP |
18 |
58,038,332 |
58,106,475 |
RGD:5509061 |
MGI |
| G |
Slc12a2 |
solute carrier family 12, member 2 |
|
|
IAGP |
18 |
58,038,332 |
58,106,475 |
RGD:5509061 |
MGI |
| G |
Slc12a6 |
solute carrier family 12, member 6 |
|
|
IAGP |
2 |
112,106,471 |
112,203,320 |
RGD:5509061 |
MGI |
| G |
Slc13a5 |
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
|
|
IAGP |
11 |
72,055,496 |
72,080,106 |
RGD:5509061 |
MGI |
| G |
Slc17a8 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 |
|
|
IAGP |
10 |
89,036,765 |
89,083,994 |
RGD:5509061 |
MGI |
| G |
Slc18a3 |
solute carrier family 18 (vesicular monoamine), member 3 |
|
|
IAGP |
14 |
33,275,623 |
33,278,036 |
RGD:5509061 |
MGI |
| G |
Slc45a2 |
solute carrier family 45, member 2 |
|
|
IEA |
15 |
10,930,476 |
10,958,988 |
RGD:5509061 |
MGI |
| G |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
|
|
IAGP |
6 |
114,232,629 |
114,267,519 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
IAGP |
11 |
76,812,099 |
76,845,845 |
RGD:5509061 |
MGI |
| G |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
|
|
IAGP |
7 |
57,165,669 |
57,214,863 |
RGD:5509061 |
MGI |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
|
IAGP |
X |
70,918,472 |
70,927,841 |
RGD:5509061 |
MGI |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
|
IAGP |
X |
70,918,472 |
70,927,841 |
RGD:5509061 |
MGI |
| G |
Slc9a6 |
solute carrier family 9 (sodium/hydrogen exchanger), member 6 |
|
|
IEA |
X |
53,863,012 |
53,917,407 |
RGD:5509061 |
MGI |
| G |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
|
|
IAGP |
14 |
111,147,800 |
111,154,371 |
RGD:5509061 |
MGI |
| G |
Snai2 |
snail homolog 2 (Drosophila) |
|
|
IAGP |
16 |
14,705,952 |
14,709,478 |
RGD:5509061 |
MGI |
| G |
Snai2 |
snail homolog 2 (Drosophila) |
|
|
IAGP |
16 |
14,705,952 |
14,709,478 |
RGD:5509061 |
MGI |
| G |
Snap25 |
synaptosomal-associated protein 25 |
|
|
IAGP |
2 |
136,539,186 |
136,608,164 |
RGD:5509061 |
MGI |
| G |
Snap25 |
synaptosomal-associated protein 25 |
|
|
IAGP |
2 |
136,539,186 |
136,608,164 |
RGD:5509061 |
MGI |
| G |
Sobp |
sine oculis-binding protein homolog (Drosophila) |
|
|
IAGP |
10 |
42,722,306 |
42,894,336 |
RGD:5509061 |
MGI |
| G |
Sox1 |
SRY-box containing gene 1 |
|
|
IAGP |
8 |
12,395,519 |
12,399,555 |
RGD:5509061 |
MGI |
| G |
Srr |
serine racemase |
|
|
IAGP |
11 |
74,719,861 |
74,739,300 |
RGD:5509061 |
MGI |
| G |
Ssfa2 |
sperm specific antigen 2 |
|
|
IAGP |
2 |
79,475,582 |
79,513,123 |
RGD:5509061 |
MGI |
| G |
Syngap1 |
synaptic Ras GTPase activating protein 1 homolog (rat) |
|
|
IAGP |
17 |
27,078,397 |
27,107,590 |
RGD:5509061 |
MGI |
| G |
Tacr1 |
tachykinin receptor 1 |
|
|
IAGP |
6 |
82,352,469 |
82,510,098 |
RGD:5509061 |
MGI |
| G |
Tacr1 |
tachykinin receptor 1 |
|
|
IAGP |
6 |
82,352,469 |
82,510,098 |
RGD:5509061 |
MGI |
| G |
Tbx10 |
T-box 10 |
|
|
IAGP |
19 |
3,992,752 |
3,999,512 |
RGD:5509061 |
MGI |
| G |
Th |
tyrosine hydroxylase |
|
|
IAGP |
7 |
150,078,681 |
150,085,871 |
RGD:5509061 |
MGI |
| G |
Th |
tyrosine hydroxylase |
|
|
IAGP |
7 |
150,078,681 |
150,085,871 |
RGD:5509061 |
MGI |
| G |
Tmod2 |
tropomodulin 2 |
|
|
IAGP |
9 |
75,413,428 |
75,459,132 |
RGD:5509061 |
MGI |
| G |
Tmub1 |
transmembrane and ubiquitin-like domain containing 1 |
|
|
IAGP |
5 |
23,951,281 |
23,953,664 |
RGD:5509061 |
MGI |
| G |
Tnc |
tenascin C |
|
|
IAGP |
4 |
63,620,819 |
63,681,760 |
RGD:5509061 |
MGI |
| G |
Tnik |
TRAF2 and NCK interacting kinase |
|
|
IAGP |
3 |
28,162,136 |
28,569,507 |
RGD:5509061 |
MGI |
| G |
Tsc1 |
tuberous sclerosis 1 |
|
|
IAGP |
2 |
28,496,763 |
28,546,687 |
RGD:5509061 |
MGI |
| G |
Tuba1a |
tubulin, alpha 1A |
|
|
IAGP |
15 |
98,780,278 |
98,783,932 |
RGD:5509061 |
MGI |
| G |
Tuba1a |
tubulin, alpha 1A |
|
|
IAGP |
15 |
98,780,278 |
98,783,932 |
RGD:5509061 |
MGI |
| G |
Unc5c |
unc-5 homolog C (C. elegans) |
|
|
IAGP |
3 |
141,128,528 |
141,497,886 |
RGD:5509061 |
MGI |
| G |
Unc79 |
unc-79 homolog (C. elegans) |
|
|
IAGP |
12 |
104,240,099 |
104,422,208 |
RGD:5509061 |
MGI |
| G |
Unc79 |
unc-79 homolog (C. elegans) |
|
|
IAGP |
12 |
104,240,099 |
104,422,208 |
RGD:5509061 |
MGI |
| G |
Ush1c |
Usher syndrome 1C |
|
|
IAGP |
7 |
53,450,721 |
53,493,860 |
RGD:5509061 |
MGI |
| G |
Ush1c |
Usher syndrome 1C |
|
|
IAGP |
7 |
53,450,721 |
53,493,860 |
RGD:5509061 |
MGI |
| G |
Ush1g |
Usher syndrome 1G |
|
|
IAGP |
11 |
115,176,506 |
115,183,232 |
RGD:5509061 |
MGI |
| G |
Ush1g |
Usher syndrome 1G |
|
|
IAGP |
11 |
115,176,506 |
115,183,232 |
RGD:5509061 |
MGI |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
|
IAGP |
9 |
43,875,104 |
43,903,710 |
RGD:5509061 |
MGI |
| G |
Vgf |
VGF nerve growth factor inducible |
|
|
IAGP |
5 |
137,506,165 |
137,509,221 |
RGD:5509061 |
MGI |
| G |
Vim |
vimentin |
|
|
IAGP |
2 |
13,495,938 |
13,504,453 |
RGD:5509061 |
MGI |
| G |
Vldlr |
very low density lipoprotein receptor |
|
|
IAGP |
19 |
27,291,510 |
27,328,721 |
RGD:5509061 |
MGI |
| G |
Wfs1 |
Wolfram syndrome 1 homolog (human) |
|
|
IAGP |
5 |
37,357,343 |
37,380,221 |
RGD:5509061 |
MGI |
| G |
Whrn |
whirlin |
|
|
IAGP |
4 |
63,075,944 |
63,156,985 |
RGD:5509061 |
MGI |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
|
IAGP |
4 |
46,188,094 |
46,209,183 |
RGD:5509061 |
MGI |
| G |
Zdhhc17 |
zinc finger, DHHC domain containing 17 |
|
|
IAGP |
10 |
110,378,835 |
110,447,122 |
RGD:5509061 |
MGI |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
|
IAGP |
18 |
5,591,889 |
5,774,909 |
RGD:5509061 |
MGI |
| G |
Zic2 |
zinc finger protein of the cerebellum 2 |
|
|
IEA |
14 |
122,874,606 |
122,879,550 |
RGD:5509061 |
MGI |
| Q |
Actd1_m |
activity-distance traveled 1 (mouse) |
|
|
IAGP |
1 |
86,894,727 |
120,894,829 |
RGD:5509061 |
MGI |
| Q |
Actd2_m |
activity-distance traveled 2 (mouse) |
|
|
IAGP |
5 |
4,685,340 |
38,685,472 |
RGD:5509061 |
MGI |
| Q |
Actd3_m |
activity-distance traveled 3 (mouse) |
|
|
IAGP |
5 |
96,601,539 |
130,601,687 |
RGD:5509061 |
MGI |
| Q |
Actd4_m |
activity-distance traveled 4 (mouse) |
|
|
IAGP |
9 |
32,331,368 |
66,331,662 |
RGD:5509061 |
MGI |
| Q |
Amdt1_m |
amphetamine distance traveled 1 (mouse) |
|
|
IAGP |
1 |
3,861,477 |
37,861,744 |
RGD:5509061 |
MGI |
| Q |
Amdt2_m |
amphetamine distance traveled 2 (mouse) |
|
|
IAGP |
10 |
3,654,078 |
37,654,202 |
RGD:5509061 |
MGI |
| Q |
Axtofa1_m |
anxiety-open field activity 1 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Axtofa2_m |
anxiety-open field activity 2 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Axtofa3_m |
anxiety-open field activity 3 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Axtofa3_m |
anxiety-open field activity 3 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Axtofa4_m |
anxiety-open field activity 4 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Axtofa5_m |
anxiety-open field activity 5 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Axtofa6_m |
anxiety-open field activity 6 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Axtofa7_m |
anxiety-open field activity 7 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Bslm4_m |
basal locomotor activity 4 (mouse) |
|
|
IAGP |
1 |
159,558,864 |
193,559,001 |
RGD:5509061 |
MGI |
| Q |
Bw8q1_m |
body weight at 8 weeks QTL 1 (mouse) |
|
|
IAGP |
1 |
163,303,827 |
197,117,633 |
RGD:5509061 |
MGI |
| Q |
Cocia10_m |
cocaine induced activation 10 (mouse) |
|
|
IAGP |
9 |
24,695,932 |
58,696,113 |
RGD:5509061 |
MGI |
| Q |
Cocia11_m |
cocaine induced activation 11 (mouse) |
|
|
IAGP |
13 |
37,579,545 |
71,579,665 |
RGD:5509061 |
MGI |
| Q |
Cocia12_m |
cocaine induced activation 12 (mouse) |
|
|
IAGP |
16 |
59,817,838 |
93,817,961 |
RGD:5509061 |
MGI |
| Q |
Cocia13_m |
cocaine induced activation 13 (mouse) |
|
|
IAGP |
17 |
30,859,524 |
64,859,654 |
RGD:5509061 |
MGI |
| Q |
Cocia14_m |
cocaine induced activation 14 (mouse) |
|
|
IAGP |
18 |
55,180,072 |
89,180,196 |
RGD:5509061 |
MGI |
| Q |
Cocia5_m |
cocaine induced activation 5 (mouse) |
|
|
IAGP |
1 |
71,315,827 |
105,315,981 |
RGD:5509061 |
MGI |
| Q |
Cocia6_m |
cocaine induced activation 6 (mouse) |
|
|
IAGP |
5 |
20,920,888 |
54,921,029 |
RGD:5509061 |
MGI |
| Q |
Cocia7_m |
cocaine induced activation 7 (mouse) |
|
|
IAGP |
5 |
129,673,682 |
152,453,783 |
RGD:5509061 |
MGI |
| Q |
Cocia8_m |
cocaine induced activation 8 (mouse) |
|
|
IAGP |
6 |
12,701,222 |
46,701,334 |
RGD:5509061 |
MGI |
| Q |
Cocia9_m |
cocaine induced activation 9 (mouse) |
|
|
IAGP |
7 |
42,053,491 |
76,053,640 |
RGD:5509061 |
MGI |
| Q |
Dloc1_m |
duration of locomotor activity 1 (mouse) |
|
|
IAGP |
2 |
152,101,357 |
181,880,033 |
RGD:5509061 |
MGI |
| Q |
Dloc2_m |
duration of locomotor activity 2 (mouse) |
|
|
IAGP |
18 |
59,003,023 |
90,755,245 |
RGD:5509061 |
MGI |
| Q |
Loca1_m |
locomotor activity 1 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Loca2_m |
locomotor activity 2 (mouse) |
|
|
IAGP |
16 |
1 |
22,682,803 |
RGD:5509061 |
MGI |
| Q |
Loco1_m |
locomotor activity 1 (mouse) |
|
|
IAGP |
3 |
133,419,220 |
167,419,369 |
RGD:5509061 |
MGI |
| Q |
Loco2_m |
locomotor activity 2 (mouse) |
|
|
IAGP |
17 |
26,711,030 |
60,711,172 |
RGD:5509061 |
MGI |
| Q |
Mlca1_m |
modifier of locomotor activity 1 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Mlca2_m |
modifier of locomotor activity 2 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Mlca4_m |
modifier of locomotor activity 4 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Mlca5_m |
modifier of locomotor activity 5 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
hyperactivity elicited by ethanol administration
|
| G |
Drd4 |
dopamine receptor D4 |
|
|
IAGP |
7 |
148,477,905 |
148,480,900 |
RGD:5509061 |
MGI |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6 |
|
|
IAGP |
4 |
138,617,324 |
138,630,704 |
RGD:5509061 |
MGI |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
|
IAGP |
12 |
3,954,951 |
3,960,618 |
RGD:5509061 |
MGI |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
|
IAGP |
11 |
98,210,052 |
98,219,109 |
RGD:5509061 |
MGI |
| G |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
|
|
IAGP |
6 |
114,232,629 |
114,267,519 |
RGD:5509061 |
MGI |
| Q |
Actre1_m |
activity response to ethanol 1 (mouse) |
|
|
IAGP |
1 |
159,558,864 |
193,559,001 |
RGD:5509061 |
MGI |
| Q |
Actre1_m |
activity response to ethanol 1 (mouse) |
|
|
IAGP |
1 |
159,558,864 |
193,559,001 |
RGD:5509061 |
MGI |
| Q |
Actre2_m |
activity response to ethanol 2 (mouse) |
|
|
IAGP |
2 |
97,118,625 |
131,118,787 |
RGD:5509061 |
MGI |
| Q |
Actre2_m |
activity response to ethanol 2 (mouse) |
|
|
IAGP |
2 |
97,118,625 |
131,118,787 |
RGD:5509061 |
MGI |
| Q |
Actre5_m |
activity response to ethanol 5 (mouse) |
|
|
IAGP |
3 |
130,806,689 |
164,806,831 |
RGD:5509061 |
MGI |
| Q |
Eila1_m |
ethanol induced locomotor activity 1 (mouse) |
|
|
IAGP |
1 |
160,571,382 |
194,571,503 |
RGD:5509061 |
MGI |
| Q |
Eila2_m |
ethanol induced locomotor activity 2 (mouse) |
|
|
IAGP |
6 |
70,375,892 |
104,376,028 |
RGD:5509061 |
MGI |
| Q |
Eila3_m |
ethanol induced locomotor activity 3 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Elda3_m |
ethanol induced low dose activation 3 (mouse) |
|
|
IAGP |
2 |
111,157,520 |
145,157,637 |
RGD:5509061 |
MGI |
| Q |
Elda4_m |
ethanol induced low dose activation 4 (mouse) |
|
|
IAGP |
4 |
29,345,518 |
63,345,648 |
RGD:5509061 |
MGI |
| Q |
Etohr_m |
ethanol response acute (mouse) |
|
|
IAGP |
2 |
63,015,767 |
97,015,926 |
RGD:5509061 |
MGI |
| Q |
Slms1_m |
sensitivity to locomotor stimulants 1 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
| Q |
Slms2_m |
sensitivity to locomotor stimulants 2 (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
induced hyperactivity
|
| G |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
|
|
IAGP |
9 |
107,302,211 |
107,431,674 |
RGD:5509061 |
MGI |
| G |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
|
|
IAGP |
9 |
107,302,211 |
107,431,674 |
RGD:5509061 |
MGI |
| G |
Cars2 |
cysteinyl-tRNA synthetase 2 (mitochondrial)(putative) |
|
|
IEA |
8 |
11,514,017 |
11,550,771 |
RGD:5509061 |
MGI |
| G |
Cplx2 |
complexin 2 |
|
|
IAGP |
13 |
54,472,713 |
54,485,278 |
RGD:5509061 |
MGI |
| G |
Disc1 |
disrupted in schizophrenia 1 |
|
|
IAGP |
8 |
127,578,095 |
127,785,051 |
RGD:5509061 |
MGI |
| G |
Drd2 |
dopamine receptor D2 |
|
|
IAGP |
9 |
49,148,767 |
49,215,319 |
RGD:5509061 |
MGI |
| G |
Drd2 |
dopamine receptor D2 |
|
|
IAGP |
9 |
49,148,767 |
49,215,319 |
RGD:5509061 |
MGI |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
|
IAGP |
17 |
35,035,444 |
35,050,992 |
RGD:5509061 |
MGI |
| G |
Eif4h |
eukaryotic translation initiation factor 4H |
|
|
IAGP |
5 |
135,095,746 |
135,115,198 |
RGD:5509061 |
MGI |
| G |
En1 |
engrailed 1 |
|
|
IAGP |
1 |
122,499,064 |
122,504,568 |
RGD:5509061 |
MGI |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
|
IAGP |
10 |
57,504,729 |
57,508,256 |
RGD:5509061 |
MGI |
| G |
Galc |
galactosylceramidase |
|
|
IAGP |
12 |
99,440,510 |
99,497,547 |
RGD:5509061 |
MGI |
| G |
Glb1 |
galactosidase, beta 1 |
|
|
IAGP |
9 |
114,310,237 |
114,383,495 |
RGD:5509061 |
MGI |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
|
IAGP |
11 |
56,825,193 |
57,143,746 |
RGD:5509061 |
MGI |
| G |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
|
|
IAGP |
9 |
4,417,893 |
4,796,234 |
RGD:5509061 |
MGI |
| G |
Hfe |
hemochromatosis |
|
|
IAGP |
13 |
23,795,710 |
23,802,680 |
RGD:5509061 |
MGI |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
|
IEA |
16 |
94,970,290 |
95,219,303 |
RGD:5509061 |
MGI |
| G |
Lmo4 |
LIM domain only 4 |
|
|
IAGP |
3 |
143,851,494 |
143,868,219 |
RGD:5509061 |
MGI |
| G |
Lphn3 |
latrophilin 3 |
|
|
IAGP |
5 |
81,450,618 |
82,224,755 |
RGD:5509061 |
MGI |
| G |
Shank3 |
SH3/ankyrin domain gene 3 |
|
|
IAGP |
15 |
89,330,288 |
89,390,692 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
|
|
IAGP |
6 |
112,667,965 |
112,897,260 |
RGD:5509061 |
MGI |
| G |
Srr |
serine racemase |
|
|
IAGP |
11 |
74,719,861 |
74,739,300 |
RGD:5509061 |
MGI |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
|
IAGP |
10 |
114,515,697 |
114,622,078 |
RGD:5509061 |
MGI |
nervous
|
| G |
Oca2 |
oculocutaneous albinism II |
|
|
IAGP |
7 |
63,495,141 |
63,791,887 |
RGD:5509061 |
MGI |
Term paths to the root
|